Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

The company also entered a research collaboration for its Lysoveta krill ingredient’s potential for Alzheimer’s

Related Articles

Corn and biofuels sit in beakers on a lab table.

NEW PRODUCT DEVELOPMENT

This week in nutrition news, ADM signed a memorandum of understanding (MoU) aimed at advancing carbon-reducing research. PLT Health Solutions received a license to... Read More

DSM-Firmenich at SSW 2023

NUTRITION & HEALTH NEWS

Functional ingredient provider, dsm-firmenich will present its latest strides in gut support, women’s wellness and cognitive performance innovations at Supplyside... Read More

A tractor harvests crops in a field.

BUSINESS NEWS

This week in nutrition news, the US Department of Agriculture (USDA) committed funds to bolster global food security. At the same time, Novo Nordisk and the United... Read More

Kids walking to school in a group with cute and colorful backpacks.

NUTRITION & HEALTH NEWS

As kids return to school, Balchem Human Nutrition is shining a spotlight on cognitive support solutions for kids’ neurodevelopment. The company will focus on its... Read More

Older couple walking through the woods.

NUTRITION & HEALTH NEWS

Researchers found that Adonat Premium S-adenosylmethionine (SAMe) – developed by Gnosis by Lesaffre – may repress the PSEN1 gene, a biomarker of... Read More

trans